Literature DB >> 21991269

Expanding the bipolar construct while preserving its diagnostic integrity: are we keeping the baby or the bathwater?

Joseph F Goldberg1.   

Abstract

Year:  2011        PMID： 21991269      PMCID： PMC3188764          DOI： 10.1002/j.2051-5545.2011.tb00047.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  7 in total

1.  A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.

Authors:  Andrew A Nierenberg; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Michael E Thase; Patrick J McGrath; Jonathan E Alpert; Diane Warden; James F Luther; George Niederehe; Barry Lebowitz; Kathy Shores-Wilson; A John Rush
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

2.  Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.

Authors:  Jay D Amsterdam; Justine Shults
Journal:  Am J Psychiatry       Date:  2010-04-01       Impact factor: 18.112

3.  Lithium carbonate in affective disorders. IV. A double-blind study of prophylaxis in unipolar recurrent depression.

Authors:  R R Fieve; D L Dunner; T Kumbarachi; F Stallone
Journal:  Arch Gen Psychiatry       Date:  1975-12

4.  A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.

Authors:  James G Barbee; Thomas R Thompson; Nowal J Jamhour; Jonathan W Stewart; Erich J Conrad; Frederick W Reimherr; Peter M Thompson; Richard C Shelton
Journal:  J Clin Psychiatry       Date:  2011-10       Impact factor: 4.384

5.  Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.

Authors:  Lori L Altshuler; Trisha Suppes; David O Black; Willem A Nolen; Gabriele Leverich; Paul E Keck; Mark A Frye; Ralph Kupka; Susan L McElroy; Heinz Grunze; Christina M R Kitchen; Robert Post
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

6.  A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.

Authors:  Laura Barbosa; Michael Berk; Merryll Vorster
Journal:  J Clin Psychiatry       Date:  2003-04       Impact factor: 4.384

7.  Efficacy and safety of antidepressant augmentation with lamotrigine in patients with treatment-resistant depression: a randomized, placebo-controlled, double-blind study.

Authors:  Milena Antunes Santos; Fábio Lopes Rocha; Cláudia Hara
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008
  7 in total
  1 in total

Review 1.  The Prevalence and Diagnostic Validity of Short-Duration Hypomanic Episodes and Major Depressive Episodes.

Authors:  Shefali Miller; Ellen B Dennehy; Trisha Suppes
Journal:  Curr Psychiatry Rep       Date:  2016-03       Impact factor: 5.285
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.